Company Mission

ProLung is a privately funded medical device company that has developed and tested its novel non-invasive early diagnostics of lung cancer to save or extend lives through the early risk stratification of lung cancer.  Our mission is to bring immediate non-invasive help to patients and physicians in life threatening disease and to provide a fair return on investment to shareholders and other stakeholders.


Get in touch

Whether you are a provider or investor, we warmly invite you to find out more about ProLung.

Contact Us ▸




Chief Executive Officer, President, Director

Steven C. Eror

Mr. Eror co-founded ProLung and became CEO, President and Director in February 2005.  During his career he served as CEO of MacroMed, Inc, (injectable and oral drug delivery, breast and esophageal cancer therapeutics, analgesics and immunotherapy) where he established licenses with Abbott, BMS and Diatos. He served as the CEO at Consonus (IT application service provider).  He also has served as the CFO of Pharmadigm (injectable anti-inflammatory for severe burn, asthma and wound healing).  Earlier in his career, he served as the CFO of Evans and Sutherland Computer Corporation.  In addition, he has held senior development, financial and management positions at Guardian Industries, Air Products and Chemicals and Ford Motor Company. 



Master of Business Administration, 19xx

B.A., Economics, 19xx
B.A., French, 19xx

Activities & Affiliations

  • Affiliation 1, President
  • Affiliation 2, Director


Chief Operating Officer

Michael A. Garff

Mr. Garff joined ProLung as the Chief Operating Officer in June 2009 from the Pierre Lassonde Entrepreneur Center where he served as a Director.  While there he helped to launch several biomedical and energy companies.  His passion for technology and experience with commercialization gives him uncommon perspective in manufacturing, training, supply and regulatory businesses.  Previously, Mr. Garff earned a reputation as an organization builder and effective project manager at US Bank. 



Master of Business Administration, 20xx

B.S., Business, 20xx

Activities & Affiliations

• ABCD Bar Association, Member
• Constitutional Conservation, Member



Chief Medical Officer, Director

Jeffrey S. O'Driscoll, M.D.

Jeffrey S. O’Driscoll, MD, has been treating patients in the emergency department for over 20 years. He practices at a level-1 trauma center and teaching hospital, where he served as the chair of emergency medicine for eight years. Dr. O'Driscoll has previously chaired a regional pharmacy and therapeutics committee for Intermountain Healthcare and served on their corporate pharmacy and therapeutics committee.



Doctor of Medicine, 1989

B.A., Art History, 1999

Activities & Affiliations

  • Intermountain Healthcare Emergency Department Development Team, Medical Director
  • Intermountain Healthcare Emergency Physician Information Systems Advisory Group, Consultant
  • American College of Emergency Physicians, Fellow


  • Internal Medicine, Board Certified


Board of Directors


Chairman of the Board of Directors

Todd Morgan

Mr. Morgan serves as the Chairman of the Board of ProLung. He began his career with The West Bend Company in the sales department and served as the District Manager.  He started Morgan Industries, an asphalt paving and maintenance business, growing it from one employee to 150 employees with offices in Utah and Arizona and contracting in seven western states.  He then started NuRock, a company which manufactures asphalt maintenance products.  

Activities & Affiliations

  • MPM Investment Group LP, Founder, General Partner and Manager
  • Ellison Ranching Company, Board of Directors
  • America West Bank, Board of Directors


Corporate Code of Conduct

ProLung has adopted the Code of Ethics for Senior Executives, Financial Officers, Members of the Management Executive Committee, and Directors, which constitutes a code of ethics that applies to the principal executive officer, principal financial officer, principal accounting officer, or controller, or persons performing similar functions, as defined in Item 406 of Regulation S-K under the Exchange Act.